EREG and head and neck squamous cell carcinoma: Moreover, patients with recurrent/metastatic HNSCC receiving combined treatment of cetuximab and chemotherapy, and demonstrating high AREG and EREG expression, had longer PFS and OS than those with lower expression [74].